Skip to main content
. 2012 Feb 20;4:13–20. doi: 10.2147/CPAA.S27822

Table 2.

Platelet aggregation

LTA 5 μmol/L
ADP (%)
LTA 10 μmol/L
ADP (%)
LTA 20 μmol/L
ADP (%)
VN-P2Y12 result (PRU) VN-P2Y12 inhibition (%)
PON1 QQ192 (AA) (n = 63) 31.1 ± 12.2 37.8 ± 13.7 45.2 ± 10.8 192.9 ± 70 23.8 ± 20
PON1 QR192 (AG) (n = 67)# 30.8 ± 15.7 37.7 ± 16 45.3 ± 13.6 205.9 ± 88 27.4 ± 27
PON1 RR192 (GG ) (n = 21)# 32 ± 12.8 43.6 ± 10.9 48.6 ± 11.7 239.1 ± 53 12.6 ± 17
P-value (univariate) 0.7 0.74 0.96 0.167 0.913
P-value (multivariate) 0.81 0.89 0.87 0.081 0.638

2C19*2 Carriers (n = 44)# 37.9 ± 12 45.0 ± 13.1 51.3 ± 11 234.6 ± 67 12.9 ± 14
2C19*2 Noncarriers (n = 107)# 29.9 ± 11.2 36.2 ± 14.3 43.6 ± 12 195.0 ± 78 27.7 ± 25
P-value (univariate) 0.037 0.034 0.034 0.027 0.013
P-value (multivariate) 0.04 0.036 0.034 0.014 0.012

Note:

#

Values represent the mean plus or minus the standard deviation.

Abbreviations: ADP, adenosine diphosphate; LTA, light transmittance aggregometry; PON1, paraoxonase-1; PRU, platelet reactivity units; VN, VerifyNow®.